CRAMSN is a contract research, development, and manufacturing organization (CRO, CDMO, CMO) serving the pharmaceutical industry with end-to-end solutions, from drug discovery and development to commercial-scale manufacturing.
CRAMSN is a contract research, development, and manufacturing organization that provides end-to-end solutions for the pharmaceutical industry, ranging from drug discovery to commercial-scale manufacturing. The company operates as a one-stop-shop, integrating chemistry, analytical, and manufacturing labs to support drug development programs. Its infrastructure is designed to handle production at various scales, from small-batch grams to industrial-grade tons, covering drug substances and finished dosage forms including oral solids and sterile solutions. By utilizing its integrated research park, the company provides capabilities that span key intermediates, active pharmaceutical ingredients, and specialized formulations, aiming to streamline the drug development lifecycle.
These services enable pharmaceutical partners to accelerate their go-to-market strategies by transitioning molecules from conceptual R&D to commercial launch. CRAMSN focuses on delivering efficiency, quality, and regulatory compliance to support both standalone development programs and long-term production requirements. Its model is designed to assist companies in managing the complexities of drug lifecycle management, ensuring that innovative therapies can be moved efficiently through the required development stages. The company maintains state-of-the-art facilities in Hyderabad, India, positioning itself as a strategic partner for pharmaceutical firms seeking to outsource specialized research and manufacturing tasks.